We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$193M
AUM Growth
-$1.65M
Cap. Flow
+$718
Cap. Flow %
0%
Top 10 Hldgs %
60.41%
Holding
141
New
23
Increased
22
Reduced
12
Closed
32

Top Buys

Rank Stock Value
1
INMB icon
INmune Bio
INMB
+$5.31M
2
STAA icon
STAAR Surgical
STAA
+$5.12M
3
IDYA icon
IDEAYA Biosciences
IDYA
+$2.44M
4
NVNO
enVVeno Medical
NVNO
+$1.94M
5
CVX icon
Chevron
CVX
+$1.6M

Top Sells

Rank Stock Value
1
FLNA
Filana Therapeutics
FLNA
+$3.85M
2
U icon
Unity
U
+$3.33M
3
SKIN icon
SkinHealth Systems
SKIN
+$2.9M
4
FFIV icon
F5
FFIV
+$2.71M
5
NVAX icon
Novavax
NVAX
+$2.19M

Sector Composition

Rank Sector Weight
1 Healthcare 78.61%
2 Financials 5.86%
3 Technology 3.93%
4 Communication Services 3.41%
5 Consumer Discretionary 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QH
126
Quhuo Limited Class A Ordinary Shares
QH
$15.6K
-11
Closed -$44K
RDHL
127
Redhill Biopharma
RDHL
$4.07M
-140
Closed -$964K
RKT icon
128
Rocket Companies
RKT
$39.2B
-21,700
Closed -$420K
RLMD icon
129
Relmada Therapeutics
RLMD
$571M
-24,700
Closed -$791K
FLNA
130
Filana Therapeutics
FLNA
$46.4M
-45,000
Closed -$3.85M
SKIN icon
131
SkinHealth Systems
SKIN
$91.4M
-172,750
Closed -$2.9M
TDC icon
132
Teradata
TDC
$2.47B
-11,000
Closed -$550K
TIGR
133
UP Fintech Holding
TIGR
$860M
-25,500
Closed -$739K
VKTX icon
134
Viking Therapeutics
VKTX
$3.91B
-128,500
Closed -$770K
VTGN icon
135
VistaGen Therapeutics
VTGN
$12.2M
-3,333
Closed -$315K
VTNR
136
DELISTED
Vertex Energy, Inc
VTNR
-10,500
Closed -$139K
GMBL
137
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
-2
Closed -$706K
CELL
138
DELISTED
PhenomeX Inc. Common Stock
CELL
-12,000
Closed -$538K
INFI
139
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-100,200
Closed -$300K
CLVS
140
DELISTED
Clovis Oncology, Inc.
CLVS
-12,000
Closed -$70K

Similar funds

ACT Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, ACT Capital Management held 141 positions worth $193M, down 0.85% from $195M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

ACT Capital Management's Q3 2021 filing shows 23 new, 22 increased, 12 reduced and 32 closed positions. Its largest new stake was INmune Bio: 275,000 shares worth $5.34M. The largest sale was Filana Therapeutics, an estimated $3.85M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 80% a quarter earlier, followed by Financials and Technology.

  • ACT Capital Management's largest Q3 2021 buy was INmune Bio: 275,000 shares worth $5.34M.
  • ACT Capital Management added most to STAAR Surgical in Q3 2021, an estimated $5.12M increase.
  • ACT Capital Management's biggest Q3 2021 reduction was Unity, cutting an estimated $3.33M.
  • ACT Capital Management fully exited Filana Therapeutics in Q3 2021, selling an estimated $3.85M.
  • ACT Capital Management's ten largest holdings make up 60% of its $193M portfolio in Q3 2021.
  • ACT Capital Management opened 23 new positions and closed 32 in Q3 2021.
  • ACT Capital Management's portfolio value fell 0.85% quarter-over-quarter to $193M.

Based on ACT Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.